Donate
|
Join/Renew
|
Store
|
Member Directory
|
My SNMMI
Search SNMMI.org
Search SNMMI Learning Center
Value Initiative
|
Physicians
|
Technologists
|
Scientists
|
Residents
|
Healthcare Provider
|
Patients
NEWS & PUBLICATIONS
News and Media
Newsletters
Journals
Books
MEMBERSHIP
Join/Renew
Benefits
Categories
Download a Member Application
Grants, Awards, and Scholarships
Access the Phantom Analysis Toolkit
Membership Directory
Chapters
Centers of Excellence
Councils
Member Spotlight
Women in Nuclear Medicine
SNMMI Fellow
SNMMI-TS Fellow
Council and Center Internships
EDUCATION
Learning Center
Webinars
MEETINGS & EVENTS
Calendar of Events
Webinars
2024 Annual Meeting
2024 Therapeutics Conference
2024 Mid-Winter Meeting
Nuclear Medicine & Molecular Imaging Week
ADVOCACY
Coding & Reimbursement
Legislative Efforts
Government Relations News
Radiopharmaceutical Supply News
USP 825
Technologist State Issues
Position Statements
FDA PET Drug Manufacturing Q&A
EVIDENCE & QUALITY
Clinical Guidelines and AUC
Quality
Quality and Patient Safety
Dose Optimization
About Quality & Practice
Dosimetry
RESEARCH
Clinical Trials Network
Radiopharmaceutical Therapy Central
Radiopharmaceutical Therapy Centers of Excellence
Preclinical Imaging
Nuclear Medicine Clinical Trial Group, LLC
Research: Learn More
ABOUT SNMMI
Strategic Plan
Bylaws & Procedures
Governance - SNMMI
Governance - SNMMI-TS
History
Grants, Awards, and Scholarships
Career Center
About Nuclear Medicine & Molecular Imaging
International Collaboration
Outreach
Support SNMMI
Contact Us
HOME
>
SEARCH
>
SEARCH RESULTS
Refine by Audience:
Physicians
(276)
Scientists
(271)
Media
(193)
Healthcare Provider
(165)
International
(157)
Patients
(151)
Your search for
pilot research
returned 312 results.
Selected filters:
Technologists
Displaying 41 to 50 of 312 records
Sort by:
Relevancy
Date Added
Page:
<< Prev
2
…
3
…
4
…
5
…
6
…
7
…
8
…
Next >>
SNMMI Releases New Edition of PET Study Guide
– Nov 29, 2023
SNMMI is pleased to announce the release of the third edition of its popular PET Study Guide. The updated version incorporates the latest innovations in imaging technology and FDA-approved PET radiopharmaceutical and imaging techniques and practices.
Journal of Nuclear Medicine Supplement Explores Nuclear Cardiology
– Nov 20, 2023
A new JNM supplement highlights the exciting new developments and opportunities for nuclear cardiology in the modern era of personalized cardiovascular medicine.
SNMMI Holds Joint Workshop with FDA on PET Drug Regulations
– Nov 16, 2023
On November 13 and 14, SNMMI co-hosted a workshop on PET drug manufacturing with the FDA.
Novel PET Radiotracer Facilitates Early, Noninvasive Detection of Inflammatory Bowel Disease
– Nov 14, 2023
A newly developed PET radiotracer can be used to create an inflammation map of the entire gastrointestinal tract, providing detailed information to accurately detect and stage inflammatory bowel disease, according to research published in JNM.
Bone Scans Overstage Prostate Cancer at Initial Staging Compared with PSMA PET
– Nov 9, 2023
Bone scans have been found to overstage prostate cancer at initial staging compared to PSMA PET, according to new research published in JNM.
New AI Tool for PET Imaging Allows for High-Quality, Fully Automated Evaluation of Brain Tumors
– Oct 17, 2023
A new artificial intelligence tool provides a fully automated, easy-to-use and objective way to detect and evaluate brain tumors, according to new research published in JNM.
PET Imaging Validates Use of Common Cholesterol Drug to Enhance HER2-Targeted Cancer Therapy
– Oct 12, 2023
A novel therapeutic approach combining HER2-targeted therapies with the cholesterol-lowering drug lovastatin can reduce the number of cancer treatments required to prevent tumor growth, according to research published in JNM.
Message from the President
– Oct 10, 2023
SNMMI President Helen Nadel highlights recent achievements, global collaborations, advocacy efforts, and upcoming SNMMI meetings.
Molecular Imaging and Breast Cancer - 11/8/23, Seattle, WA
– Oct 5, 2023
Dinner Symposium - Molecular Imaging and Breast Cancer: Selecting and Evaluating Targeted Treatments
FDA Approves Widely Used Imaging Agent for Respiratory Disease
– Sep 29, 2023
The FDA has approved the imaging agent Technegas for use in ventilationperfusion studies to diagnose pulmonary embolism and other respiratory pathologies.
Displaying 41 to 50 of 312 records
Page:
<< Prev
2
…
3
…
4
…
5
…
6
…
7
…
8
…
Next >>
Didn't find what you were looking for? Conduct a new search.